The Year of Ozempic

In this New Yorker article, the author reflects on 2023 as the "Year of Ozempic" - a popular prescription drug for weight loss. The article discusses the rise in popularity of Ozempic and its impact on the diet and pharmaceutical industries. It delves into the marketing strategies employed by pharmaceutical companies to promote the drug and the controversies surrounding its efficacy and potential side effects. The article also explores the societal and cultural implications of the obsession with weight loss and the desire for a quick fix. Overall, it offers a thoughtful analysis of the phenomenon surrounding Ozempic in the year 2023.